Cristal Union shifts from fuels to pharma-grade ethanol in coronavirus response

The Cristal Union Group has stopped production of bioethanol at its Arcis plant in Aube, France, to focus on ethyl alcohol for the pharmaceutical and biotechnology industries in response to the COVID-19 outbreak, Biofuels Digest reported on 17 March.

In a statement, the company said: “Cristal Union will continue to produce bioethanol in Cristanol, another large distillery of the group, but in a smaller proportion.
“As part of its social responsibility, the group is thus providing a concrete and immediate response to the explosion in demand for this type of alcohol, in particular for customers looking for disinfectant products, in a global market that is already very tense.”
Cristal Union produces 600,000M3/year of bioethanol at three production sites in France.